
Glicomaxx M 1mg/500mg Tablet SR
Marketer
Maxx Farmacia (India) LLP
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glicomaxx M 1mg/500mg Tablet SR
Diabetol Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive treatment plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize symptoms such as sweating, lightheadedness, headache, and tremors, and know how to respond. Maintain regular meals and carry readily available glucose sources, such as sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to commencement. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Glicomaxx M 1mg/500mg Tablet SR
No text provided to rephrase.
Uses of Glicomaxx M 1mg/500mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glicomaxx M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glicomaxx M 1mg/500mg SR Tablets. Ingest the tablets whole; do not break, crush, or chew them. Administer this medication with a meal.
Common Side effects of Glicomaxx M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glicomaxx M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Glicomaxx M 1mg/500mg SR Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Glicomaxx M 1mg/500mg Tablet SR works:
Glicomaxx M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol ingestion and Glicomaxx M 1mg/500mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Glicomaxx M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Medical advice is recommended.
Breast feedingUNSAFE
Extended-release Glicomaxx M tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from operating a vehicle if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glicomaxx M 1mg/500mg SR tablets; dosage modification may be necessary. Medical advice is recommended. Glicomaxx M 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glicomaxx M 1mg/500mg SR tablets cautiously, potentially requiring dose modification. A physician's consultation is recommended. For individuals with mild to moderate liver disease, initiation should be at a low dosage; however, the medication is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glicomaxx M 1mg/500mg Tablet SR :
Should you forget to take a Glicomaxx M 1mg/500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glicomaxx M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
